Positron Emission Tomographic Imaging of Copper 64– and Gallium 68–Labeled Chelator Conjugates of the Somatostatin Agonist Tyr-Octreotate

Positron Emission Tomographic Imaging of Copper 64– and Gallium 68–Labeled Chelator Conjugates of the Somatostatin Agonist Tyr-Octreotate

The bifunctional chelator and radiometal have been shown to have a direct effect on the pharmacokinetics of somatostatin receptor (SSTR)-targeted imaging agents. We evaluated three Y3-TATE analogues conjugated to NOTA-based chelators for radiolabeling with 64 Cu and 68 Ga for small-animal positron e...

Full description

Bibliographic Details
Main Authors:	Jessie R. Nedrow, Alexander G. White, Jalpa Modi, Kim Nguyen, Albert J. Chang, Carolyn J. Anderson
Format:	Article
Language:	English
Published:	SAGE Publications 2014-09-01
Series:	Molecular Imaging
Online Access:	https://doi.org/10.2310/7290.2014.00020

Similar Items

Impact of antagonist peptides and chelators on the diagnostic performance of PET/CT using gallium-68–labeled somatostatin receptor antagonists
by: Haiqun Xing, et al.
Published: (2023-03-01)

Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
by: Ruslan Cusnir, et al.
Published: (2017-01-01)

Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of <sup>177</sup>Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells
by: Rashmi G. Shah, et al.
Published: (2021-01-01)

Positron Range Corrections and Denoising Techniques for Gallium-68 PET Imaging: A Literature Review
by: Prodromos Gavriilidis, et al.
Published: (2022-09-01)

Bifunctional gallium cation chelators
by: A. G. Polivanova, et al.
Published: (2022-06-01)

QUALITY CONTROL PROGRAM FOR POSITRON EMISSION TOMOGRAPH COMBINED WITH COMPUTER TOMOGRAPH
by: E. E. Emelyanenko, et al.
Published: (2019-06-01)

Insulinoma - The incremental value of somatostatin receptor positron emission tomography
by: S T Arunraj, et al.
Published: (2017-01-01)

PET Imaging of the Neurotensin Targeting Peptide NOTA-NT-20.3 Using Cobalt-55, Copper-64 and Gallium-68
by: Hailey A. Houson, et al.
Published: (2022-12-01)

Preliminary Study of New Gallium-68 Radiolabeled Peptide Targeting NRP-1 to Detect Brain Metastases by Positron Emission Tomography
by: Albert Moussaron, et al.
Published: (2021-11-01)

Positron emission tomographic imaging in drug discovery
by: Ghosh, Krishna Kanta, et al.
Published: (2022)

Erratum to the article: “Bifunctional gallium cation chelators”
by: A. G. Polivanova, et al.
Published: (2022-11-01)

Ga-68-Edotreotide Positron Emission Tomography/Computed Tomography Somatostatin Receptors Tumor Volume Predicts Outcome in Patients With Primary Gastroenteropancreatic Neuroendocrine Tumors
by: Rosj Gallicchio, et al.
Published: (2023-01-01)

Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT
by: Michela Del Prete, et al.
Published: (2018-10-01)

In Vivo Measurement and Characterization of a Novel Formulation of [177Lu]-DOTA-Octreotate
by: Dale Bailey, et al.
Published: (2016-01-01)

Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
by: Ur, E, et al.
Published: (1993)

Modern Developments in Bifunctional Chelator Design for Gallium Radiopharmaceuticals
by: Patrick R. W. J. Davey, et al.
Published: (2022-12-01)

A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
by: Bomanji, J, et al.
Published: (1992)

Pharmacological Characterization of Veldoreotide as a Somatostatin Receptor 4 Agonist
by: Pooja Dasgupta, et al.
Published: (2021-10-01)

Advances in macrocyclic chelators for positron emission tomography imaging
by: Mengting Li, et al.
Published: (2023-10-01)

Simple, mild, one-step labelling of proteins with gallium-68 using a tris(hydroxypyridinone) bifunctional chelator: a 68Ga-THP-scFv targeting the prostate-specific membrane antigen
by: Saima Nawaz, et al.
Published: (2017-10-01)

Cyclotron production of Gallium-68 Radiopharmaceuticals using the 68Zn(p,n)68Ga reaction and their regulatory aspects
by: Ashhar, Zarif, et al.
Published: (2022)

Cryo-EM structure of the human somatostatin receptor 2 complex with its agonist somatostatin delineates the ligand-binding specificity
by: Yunseok Heo, et al.
Published: (2022-04-01)

Novel copper-64 complexes for applications in positron emission tomography
by: Betts, HM
Published: (2009)

Prognostic Role of Interleukin-23 in Prostate Adenocarcinoma: Comparison with Gallium-68 Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Computed Tomography Findings
by: Cihan Gündoğan, et al.
Published: (2021-11-01)

Impurity of Gallium-［68Ga］ Chloride Solution from Generator
by: WU Fuhai1,2,3;CHEN Mengyi1,2,3;WANG Xiaoming1,2,3;WANG Chunlin1,2,3;SUN Mingyue1,2,3;QIU Shanshan1,2,3;ZHOU Jiajun1,2,3;QIN Xiangyu1,2,3;SHEN Langtao1,2,3
Published: (2023-10-01)

[N]Ammonia Positron Emission Tomographic/Computed Tomographic Imaging Targeting Glutamine Synthetase Expression in Prostate Cancer
by: Xinchong Shi, et al.
Published: (2015-01-01)

Somatostatin Primes Endothelial Cells for Agonist-Induced Hyperpermeability and Angiogenesis In Vitro
by: Muhammad Aslam, et al.
Published: (2022-03-01)

Diagnostic Impact of Dual-Time PET/CT with <sup>68</sup>Gallium-PSMA in Prostate Cancer and <sup>68</sup>Gallium-DOTATOC in Neuroendocrine Tumors
by: Damiano Librizzi, et al.
Published: (2023-03-01)

Positron Emission Tomographic Imaging of CXCR4 in Cancer: Challenges and Promises
by: Guillaume Pierre Charles George, et al.
Published: (2015-01-01)

Calculation of the total number of radiation decay of Radiolabelled-Octreotate using non-linear mixed effect models
by: Pratiwi Nining, et al.
Published: (2024-01-01)

Imaging Tumor Vasculature Noninvasively with Positron Emission Tomography and RGD Peptides Labeled with Copper 64 Using the Bifunctonal Chelates DOTA, Oxo-DO3A. and PCTA
by: Donald T.T. Yapp, et al.
Published: (2013-06-01)

A new 68Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting
by: Rosalba Mansi, et al.
Published: (2020-08-01)

Synthesis and Physicochemical Properties of Cefepime Derivatives Suitable for Labeling with Gallium-68
by: Przemysław Koźmiński, et al.
Published: (2023-04-01)

Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors
by: Rasmus Helgebostad, et al.
Published: (2022-02-01)

Riedel's thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis: positron emission tomographic findings.
by: Drieskens, O, et al.
Published: (2002)

Intraoperative Imaging of Positron Emission Tomographic Radiotracers Using Cerenkov Luminescence Emissions
by: Jason P. Holland, et al.
Published: (2011-05-01)

Intraoperative Imaging of Positron Emission Tomographic Radiotracers Using Cerenkov Luminescence Emissions
by: Jason P. Holland, et al.
Published: (2011-05-01)

Evaluation of Positron Emission Tomographic Tracers for Imaging of Papillomavirus-Induced Tumors in Rabbits
by: Sonja Probst, et al.
Published: (2014-01-01)

68Ga-bisphosphonates for the imaging of extraosseous calcification by positron emission tomography
by: George P. Keeling, et al.
Published: (2023-09-01)

Cyclotron Production of Gallium-68 Radiopharmaceuticals Using the <sup>68</sup>Zn(p,n)<sup>68</sup>Ga Reaction and Their Regulatory Aspects
by: Zarif Ashhar, et al.
Published: (2022-12-01)